AUTOLUS THERAPEUTICS PLC (AUTL) Stock Income Statement
NASDAQ:AUTL - Nasdaq - US05280R1005 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.12M | 1.70M | 6.36M | 2.33M | 1.72M | |||
| Cost Of Goods | 10.77M | N/A | N/A | N/A | N/A | |||
| Gross Profit | -645.00K | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 240.14M | 177.23M | 173.89M | 166.65M | 169.86M | |||
| Research and Development | 130.25M | 122.31M | 137.22M | 128.65M | 128.41M | |||
| Selling, General, and Administrative Expenses | 109.89M | 54.91M | 36.67M | 38.00M | 41.45M | |||
| Operating Income | -240.79M | -175.53M | -167.53M | -164.32M | -168.15M | |||
| Interest Income/Expense | 22.07M | -28.96M | -5.40M | -3.14M | 540.00K | |||
| Other Income/Expense | 220.00K | 261.00K | 240.00K | 2.16M | 1.35M | |||
| Non Recurring Items | -637.00K | -4.17M | -520.00K | -680.00K | 0.00 | |||
| Income Before Taxes | -219.13M | -208.40M | -173.21M | -165.99M | -166.26M | |||
| Income Tax | 1.53M | -19.00K | -24.37M | -23.89M | -24.16M | |||
| Net Income | -220.66M | -208.38M | -148.84M | -142.10M | -142.09M | |||
| EBITDA | -233.07M | -168.96M | -160.11M | -155.86M | -162.49M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.87 | -1.20 | -1.57 | -1.97 | -2.76 | |||
| Non GAAP EPS | -0.87 | -1.20 | -1.57 | -1.97 | -2.77 | |||
| Statistics | ||||||||
| Gross Profit Margin | -6.37% | N/A | N/A | N/A | N/A | |||
| Profit Margin | -2180.45% | -12272.26% | -2340.25% | -6098.71% | -8261.05% | |||
| Operating Profit Margin | -2379.34% | -10337.34% | -2634.12% | -7052.36% | -9776.16% | |||
All data in USD